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1.   Introduction 
Health care and devices used to delivery and monitor health are unquestionably among the 
most important and critical elements in our society today, and they will continue to become 
even more important in the future as the world population grows, and the demand for 
improved quality and more diverse distribution of health services delivered increases. During 
the past few decades, significant improvements were done in understanding the origin of 
various diseases, in development of new and exciting tools to fight and detect diseases, and 
obviously in cost of delivering health care. Prevention and treatment are equally important as 
our society moves into the twenty first century, and these show an ever increasing need for 
better equipment and facilities to assist in delivering the highest quality health care. These 
equipments need to provide the highest performance at the lowest possible cost. In spite of 
significant progresses made in both of these areas, today there are serious limitations imposed 
on our health care delivery due to very high costs involved. Any new technology that can help 
reduce this cost will undoubtedly find a significant market and will lay the foundation for the 
development of a new generation of biomedical systems. A possible roadmap leads to the 
realization of biomedical devices and systems using microfabrication processes, traditionally 
used for manufacture integrated circuits. 
Microfabrication processes have revolutionized pharmaceutical, medical and biological fields 
since they offer the possibility for highly reproducible mass fabrication of systems with 
complex geometries and functionalities, including novel drug delivery systems and 
bionsensors (Betancourt et al., 2006). Microdevices, realized using microfabrication 
processes, have many advantages over their macroscale counterparts. For instance, 
miniaturization allows manufacturing of portable, hand-held, implantable or even injectable 
microdevices. In addition, as a result of their minute size, these microdevices need less 
sample or reagent for analysis or operation, saving money and time. Moreover, where 
materials and/or processes are inhibited by lengthy diffusion times, miniaturization provides a 
mechanism for shortening these ones. A notable example where these microdevices allow for 
significant advantages over traditional counterparts is in medical care: point of care diagnostic 
testing, which is testing performed at the patient’s bedside, permits physicians to diagnose a 
patient’s conditions more rapidly than conventional lab based testing. By using these 
microdevices to reduce the time of diagnoses, the physician is able to make better patient 
management decisions leading to improved patient outcomes and reduce the overall cost of 
care. The basic microfabrication process is based on deposition, patterning, doping and 




etching steps (Sze, 2008). Deposition consists in placing a thin layer (or film), such as an 
insulating silicon dioxide layer, on a substrate, such as a silicon wafer, using chemical or 
physical process. A light-sensitive resist, called photoresist, is then deposited on the top of the 
thin layer and patterned using photolithography (or optical lithography). Finally, the pattern is 
transferred from the photoresist layer to the thin layer by dry or wet etching process. After 
removing the remaining photoresist, a next layer can be deposited and structured, and so on. 
Doping of a semiconductor material, such as silicon, by ion implantation or diffusion process 
can be done directly after photolithography. Traditionally, silicon, glass and ceramics are used 
as substrates, dielectric, metal and polycrystalline silicon are used as thin layers and some 
particular commercial polymers, such as SU-8, are used as photoresists. These materials are 
commonly called hard materials and show superior mechanical properties which make them 
suitable for the realization of a large variety of microdevices (microprocessors, 
accelerometers, and so on). Microfabrication processes, and related materials, were developed 
for applications in the semiconductor industry and are, consequently, not specific for 
biological, medical and other applications. In some fields, such as biological and biomedical, 
the use of the hard materials is not the more suitable choice (Quake et al., 2000). For example, 
many biomedical applications require delicate surface chemistry that is difficult to achieve 
with high temperatures required to bond silicon and glass. The so called soft materials, mostly 
based on polymers, such as hydrogel, polydimethylsiloxane (PDMS), norland optical 
adhesive (NOA), can be used to overcome many of the limitations of the hard materials. 
Polymers are inexpensive, biocompatible therefore provide a more suitable interface with 
biological tissue, reducing irritation and scarring, and can be used in disposable devices. A 
specific group of fabrication processes, called soft lithography, was developed to realize 
microdevices using soft materials (Gates et al., 2005; Lipomi et al., 2012). Some of them are 
microcontact printing, microtransfer molding and replica molding. The combination of hard 
materials and processes with soft ones allows to benefit from the advantages of both, 
providing the realization of microdevices with functionalities that are difficult to achieve with 
only hard materials and processes or only soft ones. Microfabricated devices, like 
microelectromechanical systems (MEMS), lab-on-a-chip (LoC) and micro-total analysis 
systems (micro-TAS), have been designed for more than thirty years, but only in the last few 
years they are gaining great success. High throughput, small sample volumes, high surface-
area-to-volume ratio, commercially scale-up and so on demands in several fields, like biology 
and chemistry, have created a need for these devices. Interest in using MEMS for in vivo 
applications is started in the 1990s in the academic world. Biomedical 




microelectromechanical systems (BioMEMS) are now a heavily researched area with a wide 
variety of important biomedical applications. In general, BioMEMS can be defined as devices 
or systems, constructed using techniques inspired from micro/nano-scale fabrication, used for 
processing, delivery, manipulation, analysis, or construction of biological and chemical 
entities. Most of the activities in the BioMEMS area are moving towards commercialization 
of these biomedical devices and systems (Ziaie et al., 2004). For example, a MEMS based 
DNA sequencer developed by the Cepheid is currently being installed in post offices across 
USA for bioagent detection. BioMEMS drug delivery systems are also actively targeted by 
many investigators and companies as is evident, for example, from current efforts by 
MicroCHIPS, to commercialize an electronically activated drug delivery microchip, by 
ChipRx, to introduce systems that integrate silicon and electroactive polymer technologies for 
controlled delivery, and by iMEDD, to develop nanoporous membranes and micromachined 
particles for a variety of drug delivery applications. Large efforts are dedicated to realize 
others commercial BioMEMS, such as microneedles based devices for transdermal drug 
delivery and transdermal biosensing, and microfluidic device for microdialysis. 
The aim of the scientific research investigated in these three years of PhD course is to define 
the fabrication procedures, based on lithographic processes on both hard and soft materials, 
for the realization of innovative microdevices for biomedical applications. In particular, 
microneedles based devices for drug delivery and biosensing, and device for microfluidic 
filtration have been explored.   
Microneedles are three-dimensional structures and represent the interface between a device 
and the patient’s body for extracting, sampling or releasing physiological fluid. The length of 
microneedles should be long enough that they can penetrate epidermis and short enough not 
to reach dermis, in order to avoid any pain. The concept of microneedles was proposed in the 
1970s, but it was not realized experimentally until the 1990s when the industry of 
microelectronics provided the microfabrication tools essential to make such small structures. 
Microfabrication processes are the most promising to fabricate optimal microneedles for any 
application. The first microneedle arrays reported in literature were developed by etching the 
silicon wafer for intracellular delivery (Campbell et al., 1991). These needles were inserted 
into cells and nematodes to increase molecular uptake and gene transfection. After that, a 
number of attempts were made by various researchers to develop different designs. Several 
categories of microneedles were reported in literature for various applications. Microneedles 
can be categorized on the basis of the shape (cylindrical, conical, pyramidal, etc) (Ashraf et 
al., 2010) and feature (solid, hollow, dissolving, etc) (Chandrasekaran, 2003; Sachdeva et al., 




2011). Microneedles can also be classified on the basis of materials (Ashraf et al., 2010), 
depending on application. Most of researchers used silicon for microneedles fabrication 
(Wilke et al., 2005; Ashraf et al., 2010), since it is inexpensive, of high purity and there are a 
lot of fabrication procedures, coming from the microelectronics industry, able to manipulate 
this material. However, silicon is a brittle material and can be harmful to health. Different 
researchers have understood this critical issue and shifted to soft materials. Fabrication of 
microneedles were reported using various soft materials such as polyglycolic acid (PGA), 
poly(methyl methacrylate) (PMMA), PDMS, and so on (Aoyagi et al., 2008; Kochhar et al., 
2013). Typical lengths of microneedles are in the range of 100-300 µm for drug delivery 
(Ashraf et al., 2010; Chen et al., 2010), 1100-1600 µm for blood extraction (Tsuchiya et al., 
2005). Various fabrication techniques/processes were developed and used for microneedles 
fabrication such as hot embossing (Oh et al., 2008), laser micromachining (Bhandari et al., 
2008), micromolding (Lee et al., 2008), coherent porous silicon etching (Rajaraman et al., 
2005), photolithography (Shibata et al., 2007). Currently, the most important application areas 
of microneedles can be considered transdermal drug delivery and transdermal biosensing. 
Development of functional delivery systems for active pharmaceutical ingredients is a 
challenging task. Drugs can be administered through most common routes like oral, parenteral 
and transdermal route, as well as less explored routes such as nasal, pulmonary and buccal 
(Langer, 2001). Each of these routes has specific pros and cons. Oral drug delivery systems 
offer advantages such as patient compliance, large surface area with rich blood supply for 
absorption, low cost, easiness in engineering of drug release in stomach/intestine. However, 
limitations, such as drug degradation in gastrointestinal tract, first pass metabolism, poor 
absorption, local irritation and variability in absorption (due to factors like pH, motility, food, 
mucus layer), are associated with these drug delivery systems. The parenteral route offers 
advantages like quick onset of action, accurate drug delivery and continuous drug delivery by 
infusion. Its major limitations include pain associated with the injections, expertise required to 
drug deliver, risk of infection and difficulty in obtaining sustained drug delivery. Transdermal 
drug delivery involves the transport of drug across the skin. Optimal physiochemical 
properties are required in drug candidates for delivery via transdermal patches. Transdermal 
drug delivery offers advantages like patient compliance, avoidance of first pass metabolism, 
large surface area of skin over which to deliver the drug, quick termination of dosing. 
However, only a few products with optimum characteristics were successfully marketed to 
deliver a drug through the skin. Skin can be divided into three regions: 1) the outer most 
cellular layer, called epidermis, which contains the stratum corneum; 2) the middle layer, 




called dermis; 3) the inner most layer, called hypodermis. Skin varies in thickness, according 
to anatomic site and age of individual. The epidermis layer, whose thickness varies between 
50 and 150 µm, is made up of viable cells without a vascular network. This layer obtains its 
nutritional needs by passive diffusion through interstitial fluid. The outermost layer of the 
epidermis, that is the stratum corneum (20-40 µm), consists of dead cells, which act as a hard 
barrier. The dermis, an integrated fibro-elastic structure that has a thickness of about 500-
2000 µm, provides mechanical strength to the skin. This layer contains an extensive nervous 
and vascular network. The pain associated with parenteral drug delivery is due to possible 
damage to the nerves endings within the dermis. For drug delivery across the skin, the 
challenge is to cross the intact stratum corneum layer without causing damage to nerves 
endings. Only a few potent drug molecules, with high lipophilicity and small molecular 
weight (< 500 Da), can be administered directly through passive diffusion (Matteucci et al., 
2008). Various chemical and physical approaches were employed to improve drug penetration 
across the skin (Milewski et al., 2010). Chemical approaches include use of penetration 
enhancers, like surfactants, fatty acids/esters and solvents to dissolve the stratum corneum 
lipid or to increase the solubility of drugs. Physical approaches, like electroporation, 
ionphoresis, magnetophoresis and sonophoresis, were found suitable to create pathways for 
only few drugs across the skin. The aforementioned approaches are associated with certain 
drawbacks: chemical approaches are often associated with higher skin irritation and are 
applicable only to small molecules, while physical methods typically require a device with a 
power supply which adds to the cost and complexity. Searching for inexpensive and reliable 
way to administer the drug safely to the epidermal layer without damaging the nerve cells of 
dermis, and minimizing chances of microbial penetration, led to the development of 
microneedles (Donnelly et al., 2009).  
Integration of biorecognition and signal transduction elements is an important area of 
biosensors research. Analytical devices combining the specificity of biological systems with 
the advantages of electrochemical transduction have gained an increased popularity in the last 
two decades. Enzymatic redox reactions are particularly amenable to be interfaced with 
electrochemical transducers, since electron exchange is a key step in their natural cycle. In 
general, enzymes can operate in liquid environments or immobilized on various supports. 
Immobilized means that the enzyme is unable to move, but the enzyme activity still remains 
in the analytical device, although in a generally minor extension when compared with free 
enzymes. The main advantages of enzymes immobilized on supports compared to free 
enzymes systems are reduction of costs of operations, higher enzyme stability, ability to stop 




the reaction rapidly by simply removing the enzyme from the reaction solution, the fact that 
products are not contaminated with the enzyme and the possibility of establishing a model 
system to study enzyme action with variable applications. Enzyme based electrodes are an 
important class of biosensors where by products of enzymatic breakdown of an analyte are 
electrochemically detected. Enzyme immobilization on the electrode with maintained enzyme 
activity is a challenging task. The choice of immobilization method depends on many factors, 
such as the nature of the biological element, the type of transducer used, the physicochemical 
properties of the analyte and the operating conditions in which the biosensor should work, and 
overriding all these considerations is necessary for the biological element to exhibit maximum 
activity in its immobilized microenvironment. Generally, there are four regular methods for 
enzyme immobilization: adsorption, covalent bonding, crosslinking and entrapment (Nunes et 
al., 2006). The entrapment method is the most adapt for the realization of enzyme-based 
electrodes. This method refers to a mixture of biomaterial and monomer solution that 
polymerizes to a gel, trapping the biological component. Hydrogels are attractive materials in 
fabricating enzyme-based electrodes by entrapment method, since a hydrated gel provides an 
excellent matrix for encapsulation of functional enzymes (Pishko et al., 1991) that maintains 
intact the enzyme activity. Microneedles made by hydrogels are particularly attractive for 
making enzyme based electrodes for transdermal biosensing, because offers remarkable 
opportunities for moving microdevices from research laboratories to real field applications, 
and easy envisage to use point of care microdevices with pain free, minimally invasive, low 
cost and minimal training features, that are very attractive for both developed and emerging 
countries. Microneedles allow the realization of a new class of transdermal biosensors for 
electrochemical measurement of analytes of clinical interest, such as biomarkers, glucose, 
lactic acid, upon insertion of the needles in superficial layer of the skin. Diabetes is one of the 
leading causes of death and disability in the world. There is a large population suffering from 
this disease and the healthcare costs increase every year. It is a chronic disorder resulting from 
insulin deficiency and hyperglycemia and has a high risk of complications development for 
eyes, kidneys, peripheral nerves, heart and blood vessels. The lactic acid, or more commonly 
its negative ion called lactate, plays an important role in (sports) medicine, in the nutritional 
sector and touches environmental concerns. Determination of lactic acid concentration in 
blood is essential for the diagnosis of patient conditions in intensive care and during surgery. 
An elevated lactic acid level in blood is a major indicator of ischemic conditions of the 
respective tissue. This ischemic situation can be caused by all types of shock, suffocation and 
respiratory insufficiency, carbon monoxide or cyanide intoxication, heart failure, and so on. 




Another reason for an altered lactic acid level is a disturbed lactic acid metabolism, which 
may be caused by diabetes or absorptive abnormalities of short chain fatty acids in the colon. 
In other fields of medicine, lactic acid plays an important role as well. In sports medicine 
(training of athletes or racing animals) or space medicine, blood lactic acid levels during 
exercise are indicators for training status and fitness. Quick diagnosis and early prevention are 
critical for the control of the disease status related to these two analytes. Most of devices that 
quantify glucose level operate by measuring it in blood sample that is generally taken from 
the fingertip since this procedure provides the most accurate result, but it also causes the 
patient pain because of fingertips contain many nerve endings. Moreover, the inability of 
current devices to continuously monitor the glucose level causes the need to do repetitive 
measurements each day resulting in protracted discomforts. Among the various conventional 
analytical methods available for the determination of lactic acid, colorimetric tests and 
chromatographic analysis are the most important. However, the major part of these methods is 
complex, laborious and slow, complicated by intensive sample pretreatment and reagent 
preparation. Therefore, the development of alternatives for glucose and lactic acid detection, 
with features of pain free, minimal invasion, biocompatibility, on one side, and simplicity, 
fast, low cost, real time with no need of sample preparation, on the other side, is very 
interesting and, above all, highly required from the dimensions of the market and huge 
demand.  
Microfluidics is a multidisciplinary field of investigation, involving almost all the scientific 
branches of knowledge, such as physics, biology, engineering, chemistry and 
microtechnology. Conceptually, the idea under microfluidics is that fluids can be precisely 
manipulated using a microdevice built with technologies developed by semiconductor 





 litres) amounts of fluids, using channels with dimensions of tenths to hundreds 
micrometres. Microfluidic devices, commonly referred to as micro-TAS and LoC, have many 
advantages as they can decrease sample and reagent consumption and increase automation, 
thus minimizing the analysis time. Microfluidic devices exploit their most obvious 
characteristic, i.e. the small size, and less obvious characteristics of fluids in microchannels, 
such as laminar flow. The small dimension of devices allow for portability, so that biological 
and chemical samples can be tested on remote sites where there could not be access to 
traditional instrumentation. Microfluidic devices are nowadays employed in chemistry, 
biology, neuroscience, bioanalysis, biomechanics and other areas of biology and biomedical 
fields (Davis, 2008; Mehta et al., 2009). In the last ten years, the integration of mass transport 




control into microfluidic devices by means of particular components, called membranes or 
more commonly filters, has showed a growing interest (De Jong et al., 2006). Filter science 
and technology is a broad and highly interdisciplinary field, where process engineering, 
material science and chemistry meet. Although the use of filters in microfluidics is spreading 
across many fields, most applications are found in analytical chemistry. Since analytical 
equipment is often sensitive to sample composition, in most cases samples cannot be directly 
analyzed and need a pretreatment. This may include selective removal of large components, 
impurities and dust on one side and low molecular weight components such as salts on the 
other. Furthermore, in many cases the concentration of the components of interest is below 
the detection limit of the analysis equipment. In such cases, removal of solvent is necessary. 
Filters can manage all these operations. Close to analytical applications, also new fields 
emerge in which filters are used, such as cell based studies, microreaction technology and fuel 
cells. Many different approaches were reported to realize microfluidic filters. A rough 
division into four fabrication methods can be made: direct incorporation of (commercial) 
filters, filter preparation as part of the device fabrication process, in situ preparation of filters 
and use of filter properties of bulk device material (De Jong et al., 2006). Currently, one of 
the most used is in situ preparation of the filter that starts with a microfluidic device and 
fabricates the filter inside it by polymerization of a photocurable hydrogel using UV light. 
The in situ photopolymerization allows creating the filter in any location of the microfluidic 
circuit without the need of a constriction region or other mechanisms that are commonly used 
to hold the beads. An additional benefit of this method is its application in existing chip 
formats, provided that the used chip material is transparent to UV light.  
After this initial introduction, the PhD thesis is composed by other five chapters, from the 
second to the sixth: 1) materials and methods; 2) microneedles; 3) transdermal delivery of 
small molecules by microneedles based hybrid patch; 4) transdermal biosensing of biological 
molecules by microneedles based enzymatic electrodes; 5) filtration of small molecules by 
filter based microfluidic device. 
The second chapter starts with a brief description of materials, hydrogels, SU-8 photoresist, 
PDMS, NOA and porous silicon, and fabrication processes, photolithography and soft imprint 
lithography, used. The description of the fabrication process, based on photographic reduction 
technique, of homemade plastic photomasks for fast prototyping of microfluidic devices is 
also reported. The chapter continues with the realization of microneedles based devices, such 
as hybrid device and enzymatic electrodes, and filter based microfluidic device using 
materials and fabrication processes previously described. 




The third chapter is dedicated to the characterization of microneedles. In the first part, 
microneedles are characterized in terms of height and base, and curvature radius of the tips. In 
the second part, the indentation hardness, quantified by a penetration test, is characterized in 
order to verify the ability of microneedles to penetrate into skin. 
A brief description of transdermal drug delivery by conventional approaches and the 
overcoming of their limits by using microneedles, topic already widely treated in this 
introduction, is summarized in the fourth chapter. The hybrid device based on microneedles, 
realized as described in the second chapter, is used for transdermal drug delivery. As proof-
of-concept, the device is used for the releasing of fluorescein molecules, comparable to a 
small drug, into a buffer solution, that mimics the human interstitial fluid.   
The fifth chapter treats briefly the novel trend on exploiting microneedles for transdermal 
biosensing of analytes of clinical interest, already widely described in this introduction. 
Microneedles based enzymatic electrodes, realized as described in the second chapter, for 
detection of glucose and lactic acid molecules are illustrated. 
The sixth chapter summarizes the microfluidic filtration, a topic of relevant interest in many 
scientific fields, already widely discussed in this introduction. A small section is dedicated to 
the characterization of the homemade plastic photomask, realized as described in the second 
chapter. Microfluidic filter fabricated inside the microfluidic device for the filtration of small 
rhodamine molecules, realized as described in the second chapter, is characterized. 
















2.   Materials and Methods 
Microfabrication, i.e. the generation of structures with dimensions in the range between tens 
of nanometers to millimeters, is essential in technology and modern science. It supports 
information technology and permeates society through its role in microelectronics, 
optoelectronics and so on. Microfabrication has its foundations in microelectronics and it will 
continue to be the basis for microprocessors, MEMS, flexible electronic devices, biomedical 
systems in the foreseeable future. Photolithography is the most successful process in 
microfabrication. It is used to pattern parts of a thin film using the UV light. Essentially, 
almost all devices with dimensions in the range between 100 nm to millimeters are 
manufactured by this process. Microfabrication is also shifting towards areas outside 
microelectronics, such as biotechnology and biochemistry (Bhansali et al., 2012). Materials 
science gives great support to development of innovative application of microfabrication: 
traditional materials are defined as hard materials, since the most used one is the 
semiconductor silicon, but in some of these fields, there is the need to use a set of materials, 
the so-called soft materials, much more larger than the classic one, which comprises 
polymers, hydrogels and also biological matter. A high number of new microfabrication 
processes, the soft lithography processes, has been demonstrated for fabricating high quality 
structures with sizes ranging from 30 nm to hundreds of micrometers (Rogers et al., 2005; 
Qin et al., 2010). One of the most famous processes is the soft imprint lithography that 
consists in transferring a pattern from a soft structure to an imprint material. 
This chapter is divided in two parts: the first part is dedicated to the description of 
microfabrication processes, photolithography and soft imprint lithography, together with soft 
and hard materials used, in particular hydrogels, SU-8 photoresist, PDMS, NOA and porous 
silicon; in the second part, these microfabrication processes and materials are illustrated in 
practical realization of some devices, such as hybrid device and enzymatic electrodes based 
on microneedles, and microfluidic device based on filter. 
2.1.  Materials 
Materials traditionally used in microfabrication are silicon, and silicon related materials such 
as silicon nitrides and oxides, porous silicon, amorphous silicon and so on, but also metals 
(gold, aluminum, platinum, nickel, chromium), glasses of many different kind. In 
photolithography, some particular light sensitive commercial polymers, note as photoresists, 
are commonly exploited. Most of them are expensive and primarily limit the use in some 
applications, like in vivo application, due to the bio-incompatibility. In order to overcome 




these limitations, there is the need of alternative materials, such as soft materials. In the 
following, hard and soft materials are described in details.  
2.1.1. Hydrogels 
Hydrogels are polymeric networks able to swell and/or retain aqueous solutions. Hydrogels 
are attractive materials in fabrication of biodevices, since a hydrated gel provides an excellent 
matrix for encapsulation of functional biological molecules, such as enzymes and peptides. 
Main advantages of hydrogels are briefly summarized in the following: 1) micropatterning by 
photolithography; 2) development of biocompatible tissue/sensor interface; 3) near-
physiological conditions that minimize protein denaturation helping them to carry out their 
full biological functions; 4) three-dimensional geometry enables them to contain large 
quantity of sensing reagent, thereby increasing their signal-to-noise ratio and sensitivity. 
Hydrogels are divides in two types: natural, like alginates, chitosan and synthetic, as 
poly(ethylene glycol) diacrylate (or PEGDA), polyacrylamide and so on. One of the most 
widely used is the PEGDA, available commercially from Sigma Aldrich. PEGDA is a 
hydrophilic and biocompatible hydrogel that has been suggested for use in a variety of 
biomedical applications (Oh, 2009). PEGDA is poorly immunogenic, non-toxic, is readily 
cleared by the kidneys and is approved by the Food and Drug Administration for internal 
consumption. Moreover, it is an elastic material. PEGDA is commercially available over a 
wide range of molecular weights (Mn) from low, that means polymer with tight mesh, to high 
values, that means polymer with wide mesh. PEGDA with high Mn is useful in applications 
that require an hard material, such as the realization of microneedles for skin penetration, 
instead PEGDA with low Mn is adapt in those cases that need of a robust material but not so 
hard, like a microfluidic filter for the separation of biological samples. The key chemical 
constituent of the PEGDA is showed in Figure 2.1. 
 
 
Figure 2.1 Chemical composition of the PEGDA with molecular weight Mn. 
 
The terminal acrylates groups, in presence of a photoinitiator and exposed to UV light, allow 
the hydrogel to be crosslinked at room temperature, in order to form an insoluble hydrogel 
network. Photoinitiators most frequently used are 2-hydroxy-2-methyl-1-phenyl-propan-1-one 




or known as darocur 1173 (see Figure 2.2 (A)) and 2-hydroxy-2-methylpropiophenone (see 
Figure 2.2 (B)), available commercially from BASF and Sigma Aldrich, respectively. 
 
 
Figure 2.2 Chemical composition of 2-hydroxy-2-methyl-1-phenyl-propan-1-one (A) and 2-hydroxy-2-
methylpropiophenone (B). 
 
2.1.2. SU-8 photoresist 
SU-8 (see Figure 2.3) is an epoxy based high contrast photoresist, designed for 
micromachining and other microelectronic applications, where a thick, chemically and 
thermally stable image is desired. 
 
 
Figure 2.3 Chemical composition of the main constituent in SU-8 photoepoxy: eight oligomers are available for 
a high degree of crosslinking upon photoexposure. 
 
SU-8 is available commercially from MicroChem in different viscosities, thus enabling a 
wide range of thicknesses (0.5 to 650 μm with a single coat process) that can be obtained 
(MicroChem). SU-8 photoresist has excellent imaging characteristics and is able of producing 
very high aspect ratio structures. SU-8 is a negative photoresist, therefore is best suited for 
applications where it is casted, cured and left permanently on the device, like in the 
fabrication of a microfluidic device. 
 
(A) (B)





PDMS is available commercially from several companies, but the most famous is the silicone 
elastomer kit from Dow Corning called Sylgard 184. It contains a base and a curing agent 
that, once mixed, polymerize to form PDMS (Ottosen, 1999). The key chemical constituents 
of the PDMS are two and they are showed in Figure 2.4. 
 
 
Figure 2.4 Key PDMS pre-cursors, where (A) is a vinyl-terminated siloxane oligomer and (B) is a shorter, 
partially hydrosilane-terminated siloxane oligomer. The base contains (A) and a platinum complex, whereas the 
curing agent contains (A) and (B). Each methyl-hydrosiloxane oligomer contains a minimum of three 
hydrosilane (Si-H) groups available as hydrosilation reaction sites. 
 
Both components of the kit contain siloxane oligomers terminated with vinyl groups (see 
Figure 2.4 (A)). The curing agent also includes cross-linking siloxane oligomers (see Figure 
2.4 (B)), which each contains at least three silicon-hydride bonds (Si-H). The base includes a 
platinum-based catalyst that cures the elastomer by an organometallic cross-linking reaction. 
When the base and the curing agent are mixed together, hydrosilation takes place between the 
vinyl (SiCH=CH2) and hydrosilane (SiH) groups of the copolymer pre-cursors, forming Si-
CH2-CH2-Si linkages. The hydrosilane groups provide multiple reaction sites, giving rise to 
three-dimensional cross-linking. One advantage of this type of reaction is that no waste 
products are generated. Increased temperature will accelerate the cross-linking reaction. 
Changing the curing agent-to-base ratio alters the properties of the resulting cured elastomer: 
as the ratio of curing agent-to-base increases, more rigid elastomer results. A ratio of 1:10 
guarantees a good trade-off between flexibility and rigidity. The properties of PDMS are 
surprisingly close to those could be obtained from glass and plastic. It is flexible and 
reversibly deformable. Many of the properties (optical, electrical, mechanical) exhibited by 








2.1.4. Norland optical adhesive 
NOA is a single component liquid adhesive, available commercially from Norland Products, 
that cures in seconds to an hard polymer when exposed to UV light (Norland Products). NOA 
is sensitive to the UV light with a wavelength range from 320 to 380 nm, with peak sensitivity 
around 365 nm. The outstanding characteristic of this adhesive is its extremely fast cure. To 
fully cure the material requires 2 J/cm
2
 of energy. NOA cures to a hard film, but it will not 
become brittle. NOA cures not before the desired time. It is also extremely stable when not 
exposed to UV light. It has a small amount of resiliency that provides strain relief from 
vibrations or temperature extremes. This toughness insures long term performance of the 
adhesive bond. NOA cures from the surface down and longer cures are required for thicker 
films to allow UV light to penetrate to the full depth. This adhesion improves with age, with 
optimum adhesion reached after room temperature aging for one week. This optimum 
adhesion can be accelerated by aging at 50 °C for 12 hours. The cured adhesive can withstand 
temperatures from -150 °C to 125 °C. Many of the properties (optical, mechanical, etc) 
exhibited by NOA are very desirable for fabricating microfluidic devices. 
2.1.5. Porous silicon 
Porous silicon can be simply described as a network of air holes in a silicon matrix. In most 
cases, the porous silicon structure is formed by electrochemical dissolution of a doped 
crystalline silicon wafer in hydrofluoric acid (HF) based solution (Smith et al., 1992). In the 
anodic I-V curve of silicon in HF based solution, showed in Figure 2.5, it’s possible to 
distinguish three regions, called A, B, C. 
  
 
Figure 2.5 Regions of pore formation (A), transition between pore formation and silicon electropolishing (B) 
and silicon electropolishing (C).  
 
Pore formation takes place in region A. At anodic overpotentials in excess of the current peak, 
region C, silicon electropolishes. At intermediate overpotentials, region B, a transition zone 




exists where pore formation and electropolishing compete for control over the surface 
morphology. The resulting structure within the region B is generally porous in nature, but the 
pore diameters increase rapidly as the electropolishing potential is approached. Porous silicon 
shows a great variety of morphologies dependent on the doping type and level of the silicon 
substrate and the electrochemical etching parameters. Usually for a given substrate and 
electrolyte, only one type of pore structure can be obtained. The International Union of Pure 
and Applied Chemistry guidelines define ranges of pore sizes that exhibit characteristic 
absorption properties: pores characterized by a diameter ≤ 2 nm define microporous silicon; 
for sizes in the range 2-50 nm the porous silicon is mesoporous; pores diameters > 50 nm are 
typical of macroporous silicon. The porous silicon is an ideal material as optical biosensor 
transducer and it allows the label-free detection (Dhanekar et al., 2013). Its principal 





); 3) rapidly and effectively interaction with chemical species; 4) evident changes 
in several physical properties usable for label-free sensing (reflectivity, photoluminescence, 
electrical conductivity, optical waveguiding, etc); 5) easy integration in hybrid systems 
(MEMS, LoC, etc); 6) compatibility with microelectronic technologies; 7) chemically 
modification of its surface possible to enhance selectivity in analyte detection. The label-free 
sensing mechanism used is based on the change of the porous silicon refractive index on 
exposure to the substances to be detected, due to their infiltration into the pores; the 
consequence of the refractive index variation is a change in the reflectivity/transmittivity 
spectrum of the photonic structure. Photonic structures as porous silicon resonant photonic 
structures as Fabry-Perot interferometers, Bragg reflectors, optical microcavities, are realized 
exploiting intensively multilayer fabrication capability (Sailor, 2012). This is possible because 
the porous silicon fabrication process is self-stopping; an as etched porous silicon layer is 
depleted of holes and any further etching only occurs at the pores tips. The refractive index 
modulation of a porous silicon multilayered structure can be realized by alternating different 
proper currents densities during the electrochemical etching of crystalline silicon. 
2.2.  Microfabrication processes 
Microfabrication processes, like photolithography and soft imprint lithography, allow the 
patterning of a material. Although the photolithography is the most used, the soft imprint 
lithography is gaining consensus in some fields like biology and chemistry. In the following, 
these two microfabrication processes are described. 
 





Photolithography is a standard process in microfabrication for transferring a geometrical 
pattern from a photomask to a photoresist deposited on a substrate. The process sequence, 
illustrated in Figure 2.6 and described in details in literature (Sze, 2008), can be summarized 
in the following steps: 
1) spin coat: the photoresist is spin coated onto the substrate to the desired thickness; 
2) soft bake: the photoresist is warmed on a hotplate to evaporate the solvent; 
3) exposure: the photoresist is exposed to UV light with a quartz/chrome photomask by a 
mask aligner in hard, soft or flood (that is without photomask) contact mode; 
4) post exposure bake: the photoresist is again warmed on a hotplate to harden the 
exposed or unexposed regions depending on the photoresist type, negative or positive 
respectively; 
5) development: a solvent is used to dissolve unexposed or exposed regions (depends on 
the photoresist type, negative or positive respectively), leaving a relief structure of 
photoresist on the substrate. 
 
 
Figure 2.6 Schematic of the photolithographic process sequence for structuring a layer of photoresist (not to 
scale): (A) spin coat; (B) soft bake; (C) exposure; (D) post exposure bake; (E) development. 
 
Some devices illustrated in the next paragraphs are realized using the photolithographic 

















2.2.2. Soft imprint lithography 
In order to fabricate NOA device containing microfluidic channels, the soft imprint 
lithography process is used. It consists to transfer a pattern from a soft structure to an imprint 
material. This process can be divided mainly in two parts: 
1) fabrication of the PDMS stamp by soft lithography replica molding process; 
2) fabrication of the device in NOA from the PDMS stamp. 
As well described by many texts (Qin et al., 2010), the steps to fabricate a stamp in PDMS by 
soft lithography replica molding can be summarized as (see Figure 2.7 (A)-(C)): 
1) the SU-8 mould is fabricated by patterning SU-8 phototoresist, with desired thickness, 
on a silicon substrate using photolithography (all parameters, like soft bake time, 
exposure time and so on are reported in details on the SU-8 datasheet (MicroChem));     
2) the SU-8 mould is silanized exposing it to trimethylchlorosilane (TMCS) vapours for 
20 minutes in order to facilitate the future removal of the PDMS stamp from the SU-8 
mould; 
3) to form the PDMS, one part of curing agent and ten parts of base (by volume) are 
mixed rather carefully; 
4) the mixture, full of air bubbles, is degassed under vacuum for 30 minutes or more; 
5) the PDMS is dispensed onto SU-8 mould avoiding to trap air; 
6) the SU-8 mould with the PDMS above is cured through heating at 80 °C for 1 hour; 
7) the PDMS stamp is peel off from the SU-8 mould.   
The process for producing a microfluidic device in NOA, described in details in this text 
(Bartolo et al., 2008), is illustrated in Figure 2.7 (D)-(H). It is can be sketched in the following 
points: 
1) the opposite of the PDMS stamp, called PDMS anti-stamp, is fabricated from the 
PDMS stamp; 
2) the PDMS anti-stamp is put in contact with a flat PDMS and the empty space between 
them is filled with NOA; 
3) all this is exposed to UV light for 10 s at 40 mW/cm2 without photomask in order to 
partially polymerize the NOA; 
4) the PDMS anti-stamp is removed, the remainder part is pressed against a glass slide 
and exposed to UV light for 10 minutes at 40 mW/cm
2
 without photomask in order to 
complete the polymerization of the NOA; 
5)  the flat PDMS is removed. 





Figure 2.7 Scheme process to fabricate a microfluidic device in NOA by soft imprint lithography (not to scale): 
(A) fabrication of the SU-8 mould using photolithography; (B) fabrication of the PDMS stamp; (C) PDMS stamp 
after peeling; (D) fabrication of the PDMS anti-stamp; (E) filling the space between PDMS anti-stamp and flat 
PDMS with NOA; (F) exposure to UV light without photomask; (G) removing of the PDMS anti-stamp and 
exposure to UV light without photomask; (H) removing of the flat PDMS. 
 
2.3.  Microneedles fabrication 
Microneedles are three-dimensional structures and represent key components of some 
biomedical devices, often acting as an interface between the device and the patient’s body. 
Due to well-established microelectronic fabrication technologies, silicon, and silicon related 
materials, such as silicon nitrides and silicon oxide, is one of the most used for making 
microneedles. On the other hand, silicon is fragile and definitely not a biocompatible material, 
since it can cause local inflammations or silicosis, so that even in low invasive devices it 
could result unhealthy. As alternative materials, polymers can be used to overcome intrinsic 
limitations of silicon, like PDMS, PEGDA and so on. PEGDA is particularly attractive for 
this aim because rapidly hardens at room temperature in presence of a photoinitiator on 
exposure to UV light, so that it is possible to fabricate microneedles by photolithographic 
process. 
Microneedles are made with a hydrogel, obtained mixing PEGDA 250 (Mn=250) and darocur 
1173 at 2% volume/volume (v/v), that behaves as a negative photoresist. The main steps of 
the process for producing a microneedle array by photolithography, as illustrated in Figure 2.8 
(A)-(F), are: 
1) the quantity of 1 ml of negative photoresist is deposited on a quartz slide by drop 





















photomask, obtaining about 1 mm thick layer that is the flexible support for the 
following microneedle array; 
2) a silicone vessel is fulfilled with the negative photoresist; 
3) the hardened layer of photoresist on the quartz slide is overturned and putted on the 
silicone vessel to close it; 
4) the hardened layer of photoresist on the quartz slide is exposed to UV light with a 
quartz/chrome photomask, containing circles with a specific diameter, in soft contact 
mode to the quartz slide; 
5) all this is developed in deionized water for 2 minutes, in order to remove the 
unpolymerized photoresist, and is dried with nitrogen; 
6) the quartz slide is separated from the hardened layer of photoresist by means of 
tweezers, obtaining a flexible microneedle array. 
 
 
Figure 2.8 Flow chart of the fabrication process of the microneedle array (not to scale): (A) formation of the 
photoresist layer; (B) filling of the silicone vessel with photoresist; (C) direct contact between the hardened layer 
of photoresist and the photoresist contained inside the vessel; (D) exposure to UV light with a quartz/chrome 
photomask; (E) development in deionized water; (F) separation between the quartz slide and the hardened layer 
of photoresist. 
 
Soft and post exposure bakes are not required, because this photoresist does not contain any 
solvent to be evaporate and should not be hardened by heating. 
2.4.  Microneedles based hybrid device fabrication 
Microneedles promise innovative and breakthrough applications in biomedicine, both in 
diagnostics and therapeutics. The development of microneedles has been driven in the first by 
finding a painless alternative to hypodermic injections, and interesting devices based on 
microneedles are currently progressing through clinical trials for delivery of molecules and 















functions have been imagined since it became clear that microneedles were the almost perfect 
interface between the derma and any medical device for theranostic. As a matter of fact, 
microneedles permit exchanges between outside of the human body and the interstitial fluid 
under the stratum corneum of the skin, that normally is impermeable to all molecules with 
molecular weight larger than 500 Da like antibodies and proteins. In order to produce a proof-
of-concept device for transdermal drug delivery, whose operation will be described in the 
chapter 4, porous silicon and microneedle array are combined together. 
Porous silicon structures can be optically encoded, which means that they can exhibit specific 
photonic signatures. Photonic structure based on free-standing porous silicon membrane is 
fabricated by electrochemical etching of p
++
 crystalline silicon (0.001 Ωcm resistivity, <100> 
oriented, 500 µm thick) in HF (50% in volume), deionized water, and ethanol solution (1:1:1), 
in dark and at room temperature. Before anodization dissolution, silicon substrate is immersed 
in HF solution for two minutes in order to remove native oxide layer. Time breaks of 5 s are 
used during etching process in order to recover HF concentration at dissolution edge and start 
next layer formation with zero current density: in this way, density current is always the same 
for each layer. At the end of the porous multilayer formation, the anodization current density 
is quickly increased up to 600 mA/cm
2
 for 3 s and then to 800 mA/cm
2 
for 5 s, in order to turn 
the reaction into the electrochemical polishing state and separate the porous silicon membrane 
from the silicon substrate. The etching area is 0.98 cm
2
. Porous silicon membrane is oxidized 
into absolute ethanol solution for 24 hours at room temperature, in order to make it 
hydrophilic. From the optical point of view, the porous silicon membrane behaves as a Bragg 
mirror. It is a periodic structure made alternating layers of low (nL) and high (nH) refractive 
index, or high (PH) and low (PL) porosity, respectively, whose thicknesses (dL and dH) satisfy 
the relation 2(nHdH+nLdL)=mλB, where m is the order of the Bragg condition. The layer stack 
is usually denoted as [nLnH]
N
, where N is the number of periods. The Bragg mirror is made by 
30 periods. High porosity layers are obtained applying a current density of 200 mA/cm
2
 for 
0.6 s (nL=1.60, dL=78.03 nm); low porosity layers are obtained applying a current density of 
100 mA/cm
2
 for 0.87 s (nH=1.92, dH=65.04 nm). Porosities and thicknesses are estimated by 
spectroscopic ellipsometry measurements (data not showed here). Values of refractive index 
are calculated at λ=500 nm by using a Bruggeman approximation (Aspnes et al., 1979).  
Microneedle array is realized as described in the paragraph 2.3, with these parameters: UV 
light intensity of 18 mW/cm
2, exposure time of 7.5 s and base’s diameter of 400 µm.   




The hybrid device is fabricated by assembling the porous silicon membrane, that acts as 
drugs/molecules reservoir, and the polymeric microneedle array, that allows the release of 
drugs/molecules, as showed in Figure 2.9. 
 
 
Figure 2.9 Schematic of the assembling of the hybrid device (not to scale): (A) fabrication and placing of the 
porous silicon membrane on the hardened layer of negative photoresist; (B) loading of the porous silicon 
membrane with fluorescein; (C) microneedle array fabrication; (D) assembling between the hardened layer of 
photoresist and the microneedle array. 
 
The porous silicon oxidized membrane is fabricated and placed on the hardened layer of 
negative photoresist (see Figure 2.9 (A)) and then is loaded with 50 µl of saturated aqueous 
solution of fluorescein by drop casting technique (see Figure 2.9 (B)). The porous silicon 
membrane is blocked and sealed by bonding the microneedle array (see Figure 2.9 (C)) to the 
layer of negative photoresist: drops of negative photoresist are poured around the porous 
silicon membrane and exposed to UV light at 18 mW/cm
2
 for 10 s without photomask (see 
Figure 2.9 (D)). The negative photoresist is equal to that used in the paragraph 2.3 for 
fabricating the microneedles.  
2.5.  Microneedles based enzymatic electrodes fabrication 
Transdermal biosensing by microneedles offers remarkable opportunities for moving 
biosensing technologies from research labs to real field applications, allowing realizing 
microdevices with many advantages like painless, minimal training. Microneedles allow 
realizing a novel class of transdermal biosensors for electrochemical measurement of analytes 
of interest for public health, like glucose and lactic acid. These electrochemical biosensors are 













for transdermal biosensing, whose operations will be described in the chapter 5, two 
microneedles based enzymatic electrodes have been realized, one for the detection of glucose 
and the other for the lactic acid. 
The two microneedles based enzymatic electrodes are fabricated by means of 
photolithography and sputter deposition. Microneedles based enzymatic electrodes are 
constituted by gold-coated microneedle arrays. The fabrication process is equal for both 
electrodes, therefore it is discussed only that used for making electrode for the detection of 
glucose. The microneedle array is realized in way similar to that described in the paragraph 
2.3, with these parameters: UV light intensity of 18 mW/cm
2
, exposure time of 25 s and 
base’s diameter of 400 µm. The negative photoresist, called negative photoresist 1, used in the 
first step of that process for making the flexible support is made by adding 2% v/v of darocur 
and 1% w/v of the redox mediator, vinylferrocene, to PEGDA. The vinylferrocene increases 
the conductivity of PEGDA. The negative photoresist, called negative photoresist 2, used to 
filling the silicone vessel, and therefore to make microneedles, is made by adding glucose 
oxidase enzyme (GOx) in phosphate buffered saline (PBS) (pH 6.0) at 20 mg/mL 
concentration to 90% v/v of photoresist 1. In order to electrically contact the microneedle 
array, as showed in Figure 2.10, a 160 nm thick layer of gold is deposited on the back of the 
flexible support (see Figure 2.10 (A)).  
 
 
Figure 2.10 Flow chart of the fabrication process of the electrical contact of the microneedle array (not to scale): 
(A) gold deposition on the back of the microneedle array; (B) partial waterproofing of the gold layer by hardened 
liquid silicone rubber. 
 
The deposition is made by sputtering, at room temperature with a current of 30 mA and a 
deposition time of 240 s. The gold layer is partially covered by a thin layer of commercial 
liquid silicone rubber, hardened at room temperature in 2 hours (see Figure 2.10 (B)). The 
silicon rubber film on the back of the gold layer prevents direct contact between the electrode 
and the electrolytic solution during the electrochemical characterizations. As showed in 











allow the electric contact with the electrochemical setup. However, the uncovered gold is not 
immersed into the electrolytic solution, in the course of electrochemical measurements. The 
electrode for the electrochemical detection of lactic acid is realized in the same way of that for 
the detection of glucose, but using lactate oxidase enzyme (LOx) in PBS (pH 6.5) at 15 
mg/mL concentration instead of GOx. 
2.6.  Filter based microfluidic device fabrication 
In order to fabricate the filter inside the microfluidic device made in NOA, whose operation 
will be described in chapter 6, a photomask has to be used. Usually, the photomasks, made in 
quartz/chrome, are very expensive due to the complicated fabrication process and the use of 
expensive instrumentation. In the following, it is described a cheap and practical homemade 
process to make photomask on photographic film by photographic reduction technique (see 
Figure 2.11), which are particularly suitable for the fast prototyping of microfluidic devices: 
1) designing of the reverse patterns to those to transfer to the photomask by a Computer 
Aided Design (CAD) software; 
2) scaled print (typically 10:1) of the mask patterns onto paper sheet using an office 
printer; 
3) mask patterns photographic reduction (typically 10 times) and transferring from paper 
onto photographic negative film by an enlarger used in reduction mode; 
4) chemical treatment of the photographic negative film, in order to obtain the plastic 
photomask in which there is the reverse of designed patterns. 
 
 
Figure 2.11 Scheme process to realize a plastic photomask by the photographic reduction technique (not to 
scale): (A) CAD design of photomask patterns; (B) scaled print of the photomask patterns on a paper sheet; (C) 
photomask patterns optical reduction and transferring from paper to photographic film; (D) chemical treatment 
of the plastic photomask. 
 
Filter is fabricated inside the microfluidic device by in situ photopolymerization. The material 
used to make the filter is a hydrogel obtained by mixing the 50% v/v of PEGDA 575 
(Mn=575), the 5% v/v of the photoinitiator 2-hydroxy-2-methylpropiophenone and the 45% 
(A) (B) (C) (D)




v/v of deionized water. This material behaves as a negative photoresist. Since this material is 
completely transparent and it can be hardly seen in the microchannels, 2 µL of fluospheres 
carboxylate yellow-green (1 µm diameter) are added for imaging purposes. In this way the 
filter, made by exposing this fluorescent solution to UV light, would be observable in 
fluorescence imaging, and thus it could be characterized by a microscope used in fluorescence 
mode. The circuit, constituted by two channels, is filled by this negative photoresist and only 
a specific area is exposed to UV light for 1 s at 40 mW/cm
2
 with the plastic photomask in soft 
contact mode. For the exposure, it is used a mask aligner, but others standard UV exposure 
systems, like a microscope coupled with a UV lamp or a microscope coupled to a Digital 
Micromirror Device (DMD) and a UV lamp, can be used. The homemade plastic photomask 
contains a transparent line, whose dimensions are equals to those of the filter. Then, the 
circuit is flushed with deionized water for several minutes in order to remove the 
unpolymerized photoresist, obtaining the filter inside the microfluidic device. Soft and post 
exposure bakes are not required, since this photoresist does not contain any solvent to be 
evaporate and should not be hardened by heating. 




3.   Microneedles 
Microneedles are key components of some biomedical devices, in consideration of they 
provide an interface between the device and the body of a patient for extracting, sampling or 
releasing fluidic substances (Mukerjee et al., 2004; Valdés-Ramírez et al., 2012; Liu et al., 
2013). The concept of microneedles was proposed in the 1970s, but it was not realized 
experimentally until the 1990s, when the industry of microelectronics provided the tools 
essential to make such small structures. After the first microneedle arrays reported in the 
literature (Campbell et al., 1991), a lot of papers were published on the fabrication of 
microneedles by using several fabrication methods and materials (Ashraf et al., 2011). 
Various fabrication methods were developed and used for microneedles fabrication like hot 
embossing, laser micromachining, micromolding, coherent porous silicon etching, 
photolithography. Nowadays, the photolithography process is widely used in industrial fields 
for manufacturing of microdevices such as microprocessors and MEMS. It is simple, does not 
require complicated instrumentation and is adapt for the industrial manufacturing that is on 
large scale, therefore it is the most suitable process for the fabrication of the microneedles. 
Material selection is very important to design and fabricate microneedles for any particular 
application. Many researchers used silicon for microneedles fabrication, because it is 
abundant, inexpensive, highly pure and processing is amenable to miniaturization. On the 
other hand, silicon is a brittle material and can be harmful to health. As alternative materials, 
polymers can be used to overcome intrinsic limitations of silicon, such as PDMS and 
PEGDA. PEGDA is particularly attractive for this aim because rapidly hardens at room 
temperature in presence of a photoinitiator on exposure to UV light, so that it is possible to 
fabricate microneedles by photolithographic process. 
In this chapter the microneedle array, fabricated as described in paragraph 2.3, is 
characterized. In particular, in the first part microneedles are characterized in terms of height 
and base, and curvature radius of the tips. In the second part is proved that the microneedles 
are adapted for skin penetration, measuring the indentation hardness and performing a 
penetration test. 
3.1.  Height, base and curvature radius characteristics 
Some digital images (see Figure 3.1 (A)-(B)) and optical photographs (see Figure 3.1 (C)-(D)) 
of the microneedle array, made in PEGDA and darocur by photolithographic process, 
described in the paragraph 2.3, are reported in Figure 3.1. 





Figure 3.1 Digital ((A)-(B)) and optical ((C)-(D)) images of the microneedle array based on negative 
photoresist, made of PEGDA and darocur. 
 
It is possible to see that the adhesion of the microneedle array on the photoresist layer is 
perfect and the structure can be deformed by fingers without breaking or damaging the 
microneedles. 
Results of the characterization of several microneedle array fabricated in this way are showed 
in Table 3.1, Table 3.2 and Table 3.3. 
 




A1 5 A 1340±20 
A2 7.5 A 1430±25 
A3 10 A 1600±18 
A4 12.5 A 1700±21 
A5 15 A 2240±19 
 
Table 3.1 Height of the microneedles with a light intensity of 18 mW/cm
2
 and array A. 
 




B1 5 B 1230±15 
B2 7.5 B 1430±11 
B3 10 B 1500±13 
B4 12.5 B 1700±10 
B5 15 B 2000±12 
 
Table 3.2 Height of the microneedles with a light intensity of 18 mW/cm
2





















C1 9 B 210±7 11.3±0.3 
C2 9 A 940±8 9.0±0.2 
C3 12 A 1180±15 10.8±0.2 
C4 15 A 1380±12 7.8±0.3 
C5 18 A 1450±10 2.0±0.1 
 
Table 3.3 Height of the microneedles and curvature radius of the tips of these microneedles with an exposure 
time of 7.5 s and array A, B. 
 
The quartz/chrome photomask used for the exposure to UV light in the photolithographic 
process contains two arrays of transparent circles, as it can be seen in Figure 3.2 (A): arrays A 




Figure 3.2 (A) Quartz/chrome photomask; (B) array B. 
 
Table 3.1 and Table 3.2 show the heights of the microneedles at fixed UV light intensity (18 
mW/cm
2
 for both) and array (A and B, respectively): the height grows on increasing the time 
of exposure to UV light. Table 3.3 shows the height of the microneedles and the curvature 
radius of the tips of the microneedles at fixed exposure time (7.5 s for both) and array (A and 
B): the height grows on increasing of the UV light intensity and the curvature radius is less 
than 15 µm therefore microneedles are adapt for skin penetration (Davis et al., 2004).   
 
Array A Array B
(A) (B)




3.2.  Indentation hardness and skin penetration properties 
The effective penetration of microneedles into the skin is a major issue, because microneedles 
can broke due to uneven skin surface or human error during the penetration. Microneedles 
insertion studies were typically performed in biological tissue, but this can present some 
disadvantages, in that tissue samples are often heterogeneous, unstable and difficult to obtain. 
In addition, the use of biological materials sometimes presents legal issues. Thus, it is 
desirable to overcome these limitations by using an artificial material in place of skin. The 
indentation hardness property of microneedles is compared with that of a commercial 
polymeric film layer, parafilm M, used as artificial skin very similar to the surface layer of the 
pig skin (Larrañeta et al., 2014). The indentation hardness is measured by means of 
force/distance spectroscopy tool of the atomic force microscope (AFM). The force/distance 
spectroscopy tool supports the acquisition of force vs distance curve, which is the plot of the 
force, between the AFM tip and the tip of a microneedle or the parafilm M layer, as function 
of their relative distance. The force spectroscopy plots show a greater slope, and thus a greater 
indentation hardness, of the tip of the microneedle (see Figure 3.3 (A)) compared to that of 
the parafilm M layer (see Figure 3.3 (B)). 
  
 
Figure 3.3 AFM relative indentation hardness measurements of the tip of a microneedle (A) and of a parafilm M 
layer (B). 
 
This result is essential in quantify the possibility of microneedles in tissue penetration. 
(A) (B)




In order to prove the effective insertion of microneedles into the skin, penetration test was 
performed by using eight parafilm M layers folded on themselves, that mimics the pig skin 
(Larrañeta et al., 2014). Figure 3.4 shows tilted (A), lateral (B) and top (C) views of the 
reversed first layer, once separated from the others.  
 
 
Figure 3.4 Tilted (A), lateral (B) and top (C) views of the first parafilm M layer after reversing. 
 
It is clear that the microneedles penetrate the first layer and impress their shape, molding the 
surface. 
In Figure 3.5, top views of firsts five layers of the artificial skin are showed. 
 
 
Figure 3.5 Optical microscope images of the first (A), the second (B), the third (C), the fourth (D) and the fifth 
(E) parafilm M layer after microneedles penetration. 
 
In particular, Figures 3.5 (A)-(E) show the holes that the same microneedles were performed 
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4.   Transdermal delivery of small molecules by 
microneedles based hybrid patch 
When oral administration of drugs is not feasible due to poor drug absorption or enzymatic 
degradation in the gastrointestinal tract or liver, injection using a painful hypodermic needle is 
the most common alternative. An approach that is more appealing to patients, and offers the 
possibility of controlled release over time, is drug delivery across the skin using a patch 
(Touitoi, 2002). However, transdermal delivery is severely limited by the inability of the large 
majority of drugs to cross skin at therapeutic rates due to the great barrier imposed by skin’s 
outer stratum corneum layer. To increase skin permeability, a number of different approaches 
has been studied, ranging from chemical/lipid enhancers (Cevc, 2004; Williams et al., 2012) 
to electric fields employing iontophoresis and electroporation (Denet et al., 2004; Kalia et al., 
2004) to pressure waves generated by ultrasound or photoacoustic effects (Doukas et al., 
2004; Mitragotri et al., 2004). Although the mechanisms are all different, these methods share 
the common goal to disrupt stratum corneum structure in order to create holes big enough for 
molecules to pass through. The size of disruptions generated by each of these methods is 
believed to be of nanometer dimensions, which is large enough to permit transport of small 
drugs and, in some cases, macromolecules, but probably small enough to prevent causing 
damage of clinical significance. An alternative approach involves creating larger transport 
pathways of microns dimensions using arrays of microneedles. These pathways are orders of 
magnitude bigger than molecular dimensions and, therefore, should readily permit transport 
of macromolecules, as well as possibly supramolecular complexes and microparticles. Despite 
their very large size relative to drug dimensions, on a clinical length scale they remain small. 
Although safety studies need to be performed, it is proposed that microscale holes in the skin 
are likely to be safe, given that they are smaller than holes made by hypodermic needles or 
minor skin abrasions encountered in daily life. 
In this chapter the hybrid device based on porous silicon and polymeric microneedle array, 
fabricated as described in the paragraph 2.4, is proposed as a proof-of-concept device for 
transdermal drug delivery. In particular, the device operation is described and experimental 








4.1.  Microneedles based hybrid patch 
Hybrids device (see Figure 4.1 (A)) and patch (see Figure 4.1 (B)) based on microneedle 




Figure 4.1 Hybrids device (A) and patch (B). 
 
The hybrid device includes a porous silicon free-standing membrane with a Bragg mirror 
optical structure which reflects a specific bright color in the visible. Figure 4.2 shows the 
scanning electron microscope (SEM) images of the free-standing membrane (A), made 
alternating layers of low and high porosity, and the morphology of one of those two layers 
(B), constituted of mesopores. 
 
 
Figure 4.2 SEM images of the cross-section of the free-standing porous silicon membrane (A) and of the surface 
of the porous silicon layer (B).  
 
4.2.  Optically monitored administration of fluorescein molecules 
A sketch of the device operation is showed in Figure 4.3, where the porous silicon membrane, 
that acts as drugs/molecules reservoir, is firstly loaded with the drug (see Figure 4.3 (A)), then 
the drug diffuses into the polymeric matrix of the microneedles (see Figure 4.3 (B)) and, 
finally, the drug is released into the external solution (see Figure 4.3 (C)). As a proof of 
concept, a dye molecule, 332 Da fluorescein, and PBS solution 1X at pH 7.2 are used as drug 
and external solution. PBS mimics the human interstitial fluid.  
(A) (B)
(A) (B)





Figure 4.3 (A) Loading of the porous silicon membrane with the fluorescein molecules; (B) diffusion of the 
fluorescein molecules into the nanoporous polymeric matrix of the microneedles; (C) releasing of the fluorescein 
molecules into the PBS solution due to the swelling of microneedles. All images are not to scale. 
 
Fluorescent images reported in Figure 4.4 experimentally confirm the diffusion of the 
fluorescein molecules from the porous silicon membrane into the polymeric matrix of the 
microneedles. 
 
Figure 4.4 (A) Top view of the device acquired in fluorescence mode: the blue line underlines the profile of the 
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side); (B) fluorescence intensities of the areas inside the red rectangles of (A); (C) lateral view of the device 
acquired in fluorescence mode: the blue line underlines the profile of the porous silicon membrane placed under 
the microneedles; (D) single microneedle detached from the device after fluorescein loading.  
 
The migration of the luminescent molecules from porous silicon membrane to microneedles 
starts just after the bonding of device constituents and spontaneously occurs also in absence of 
the external solution. Top view of the device, acquired in fluorescence mode, is showed in 
Figure 4.4 (A): the blue line shows the porous silicon membrane placed under the 
microneedles and the only microneedles. Only the area of microneedle array overlapping the 
porous silicon membrane is fluorescent. A quantitative estimation, by counting the 
fluorescence intensities of the areas inside the red rectangles (see Figure 4.4 (B)), reveals an 
high intensity (210 counts) for the porous silicon membrane just under the microneedle array 
(see right side of the Figure 4.4 (A)) and a low intensity (4 counts) for only microneedles 
outside the area of the porous silicon membrane (see left side of the Figure 4.4 (A)), also 
proving that polymeric microneedles do not show intrinsic fluorescence signal. Cross section 
of the whole device (see Figure 4.4 (C)) and picture of a single microneedle (see Figure 4.4 
(D)), detached from the negative photoresist layer, have been acquired in fluorescence mode. 
Both images show that the fluorescein is almost uniformly distributed from the base to the tip 
of the microneedles: this result proves that the fluorescein molecules are not chemically 
bonded neither mechanically fixed into the polymeric matrix and can easily diffuse from the 
mesoporous of the membrane to the nanoporous polymeric matrix (Li et al., 2013). The 
diffusion naturally stops when equilibrium between the fluorescein concentration into the 
porous silicon membrane and the rest of the device is reached. 
The porous silicon membrane has a double function: it acts as a drugs/molecules reservoir, 
and, since its color changes depending on what fills its pores, it can be used to optically 
monitor the drugs/molecules loaded and released from it. In Figure 4.5 (A), the reflectivity 
spectra of the porous silicon membrane after oxidation, fluorescein loading and PBS 
immersion after 2 hours are showed. The Bragg multilayer, i.e. a stack of alternating films 
with proper thicknesses and refractive indexes which satisfy the Bragg relationship, is an 
interferometric mirror that exhibits maximum reflection for a specific interval of wavelengths, 
the so called stop band. The stop band shifts if thicknesses or refractive indexes are modified: 
is this the case of porous silicon based Bragg mirror, where the stop band position depends on 
the porosity of the stack. When the porous silicon membrane is filled by molecules, the 
optical spectrum red shifts towards higher wavelengths, since the material appears denser on 
average: in case of fluorescein loading more than 100 nm of shift can be measured (see Figure 




4.5 (A)). The new position of the resonant wavelength is stable: the diffusion of fluorescein in 
the polymeric matrix does not modify the optical spectrum, i.e. there is not a relevant 
depletion of the porous silicon membrane. On the contrary, a strong blue shift (more than 50 
nm) of the spectra after immersion in PBS for 2 hours proves the release of fluorescein from 
the porous silicon membrane to the microneedles. The shifts of the optical spectrum 
correspond to changes in color of the device from violet to green and then to blue, which can 
be clearly monitored by naked eye, as showed in Figure 4.5 (B). 
 
 
Figure 4.5 Spectroscopic reflectometry (A) and naked eye (B) characterizations after oxidation, fluorescein 
loading and release of fluorescein in the PBS solution. 
 
In Table 1, the spectroscopic reflectometry data relative to the absolute position of the 
wavelength peak and the blue shift of Bragg optical structure peak are reported as function of 
immersion time in PBS (0, 2, 4, 8 and 24 hours).  
 
 Before PBS After 2h in PBS After 4h in PBS After 8h in PBS After 24h in PBS 
Peak position 508.2±0.3 450.5±0.4 444.9±0.5 445.6±0.9 436.6±0.2 
Blue shift - 57.7±0.1 63.3±0.1 62.7±0.2 71.6±0.1 
 
Table 4.1 Spectroscopic reflectometry data of absolute position and shift of Bragg optical structure peak as 
function of immersion time in PBS solution. 
 

































The fluorescence intensity as function of immersion time in PBS (0, 2, 4, 8 and 24 hours) of 
the microneedle array (see Figure 4.6) is strictly related to the blue shift of the porous silicon 
membrane optical spectrum: as a matter of fact, the blue shift indicates a depletion of the 
porous silicon tank, to which corresponds a decrease of the fluorescence intensity of the 
microneedles as the immersion time in PBS increases. The decreasing of the fluorescence 
intensity means that fluorescein molecules diffuse from the microneedles to the PBS solution. 
It is verified that the fluorescence decrease is not due to a decay of the radiative properties of 
the molecules by measuring the fluorescence intensity of loaded microneedles not exposed to 
PBS solution as a function of time, as reported in Figure 4.6.  
 
 
Figure 4.6 Changing of the fluorescence intensity of microneedles of two devices, one immersed in the PBS 
solution and the other no, as function of time. 
 
After the equilibrium is reached, the fluorescent signal does not change in time, so it is 
possible to attribute the strong emission change of the device exposed to PBS solution to a 
real dispersion of fluorescein in the external solution. 
In order to confirm that the decreasing of microneedles fluorescence intensity is due to the 
release of fluorescein in the PBS solution, those data are compared with those reported in ref. 
(Donnelly et al., 2012) as showed in Figure 4.7.  
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Figure 4.7 Comparison between the estimated fluorescein released in PBS and data of in vitro release as 
reported in ref. (Donnelly et al., 2012). 
 
Methylene blue (320 Da) loaded in hydrogel-forming microneedles patch, made of 15% w/w 
poly(methylvinylether/maelic acid) and 7.5% w/w poly(ethyleneglycol), was released and 
quantified in vitro experiment (Donnelly et al., 2012). If it was assumed that the estimated 
fluorescein was proportional to the complement of the fluorescence intensity, i.e. molecules 
released were estimated as 1-Ifn (where Ifn is the fluorescence intensity normalized to its 
maximum value), the comparison with respect to data reported in ref. (Donnelly et al., 2012) 
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5.   Transdermal biosensing of biological molecules by 
microneedles based enzymatic electrodes  
A growing general attention on public health, in particular on nutrition and sport activity, 
indicated as primary prevention of diseases, such as obesity and diabetes as well as cancer, 
supported a continuous development of diagnostic devices in the last ten years. Currently, the 
most important physiological parameters is measured in laboratories and requires dedicate 
instrumentation, not available for self-diagnostic at home. Electrochemical biosensors, and in 
particular microneedles based enzymatic electrodes, offer an unique opportunity to realize 
point of care microdevices with pain free, minimally invasive, low cost and minimal training 
features (Ventrelli et al., 2015). The immobilization of the enzyme on the electrode with 
maintained enzyme activity is the most hard task for the realization of the device. The 
immobilization method influences the performances, the response time, the sensitivity, the 
stability and the lifetime of the biosensor. The enzyme immobilizing method should promote 
a rapid propagation of generated electrons and avoid nonspecific binding and electrode 
failing. Electrode features can be optimized by using several matrices in which enzymes can 
be dispersed. Among many available from material science studies, hydrogels are excellent 
enzyme encapsulation materials, that avoid enzymatic binding, allow analyte molecules 
diffusion and interaction with the enzymes, provide near physiologic conditions and avoid 
enzymes denaturation (Yan et al., 2010). PEGDA rapidly hardens at room temperature in 
presence of a photoinitiator on exposure to UV light, therefore it gives an excellent 
encapsulation of the enzyme. Moreover, this peculiarity can be used to fabricate microneedles 
by photolithographic process. 
In this chapter two microneedles based enzymatic electrodes, realized as described in the 
parahraph 2.5, are proposed as proof-of concept devices for transdermal biosensing. In 
particular, the operation of the two devices is described and experimental proved for the 
electrochemical detection of glucose and lactic acid molecules.  
5.1.  Microneedles based enzymatic electrodes 
The enzymatic electrode for the detection of glucose, fabricated as described in the paragraph 
2.5, is showed in the Figure 5.1. 






Figure 5.1 Pictures front (A) and back (B) of the microneedles based enzymatic electrode for the detection of 
glucose. 
 
The device is completely flexible, in particular the microneedle array (see Figure 5.1 (A)) 
could be deformed without breaking, and the back is continuously covered by gold (see 
Figure 5.1 (B)), assuring a good electrical contact. The length of the microneedles is of about 
500 µm. The enzymatic electrode for the detection of lactic acid is equal to this, therefore it is 
not showed. 
5.2.  Electrochemical detection of glucose and lactic acid molecules 
A scheme of the device working principle and of the experimental setup geometry is 
illustrated in Figure 5.2. 
 
 
Figure 5.2 (A) Sketch of the three electrode cell; (B) immersion of the three electrodes inside the electrolytic 
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acid) inside the microneedles and redox interaction between the enzyme (GOx or LOx) and the analyte (glucose 
or lactic acid), with following generation of electrons. All images are not to scale. 
 
The setup is constituted of a three electrode cell (see Figure 5.2 (A)): a platinum wire is the 
auxiliary electrode, a saturated silver chloride (silver/silver chloride 3 M) is the reference 
electrode and the microneedles based enzymatic electrode (that for glucose or that for lactic 
acid) is the working electrode. The three electrodes are immersed in an electrolytic solution 
(see Figure 5.2 (B)), that mimics the interstitial fluid, made of PBS at 10 mM concentration 
(pH 7.4) mixed with 0.48 mM magnesium chloride (MgCl2), deoxygenated with nitrogen 
during the electrochemical measurements. The swelling of the polymeric matrix of the 
microneedles allow to analyte molecules (glucose or lactic acid) to penetrate into the 
microneedles and to interact with the enzyme (GOx or LOx) locked inside the porous matrix 
(see Figure 5.2 (C)), resulting in the generation of electrons collected by auxiliary electrode.  
Sensing mechanism is based on redox reactions between analyte (glucose or lactic acid) and 
enzyme (GOx or LOx), summarized in equations (1)-(3) in case of glucose and equations (4)-
(6) in case of lactic acid: through these reactions, the analyte concentration is transduced into 
an electrical current value (Heller et al., 2008; Wang, 2008). In particular, the biocatalytic 
reaction involves reduction of enzyme flavin group (FAD) in its reduced form (FADH2), 
reported in equation (1) for glucose and equation (4) for lactic acid. Glucose is oxidized to D-
glucono-1,5-lactone (equation (1)) and lactic acid is oxidized to pyruvic acid (equation (4)). 
An artificial mediator, the vinylferrocene, promotes the electrons charge transfer between 
FAD center and enzymatic electrode surface (equations (2) and (5) for glucose and lactic acid, 
respectively): vinylferroceneox and vinylferrocenered are the oxidized and reduced forms of the 
mediator. The reduced form of the mediator is then re-oxidized on the electrode, giving a 
current signal (proportional to the glucose or lactic acid concentration) while regenerating the 
oxidized form of the mediator (equation (3) for glucose and equation (6) for lactic acid). 
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Cyclic voltammetry technique is used to characterize the activity of the redox mediator 
vinylferrocene, in presence of the enzyme (GOx or LOx) incorporated into the polymeric 
matrix. During the cyclic voltammetry measurements, the potential applied between the 
working electrode and the reference electrode is linearly changed and the current between the 
working electrode and the auxiliary electrode is measured. For working electrode containing 
GOx, the potential has varied from -100 to 700 mV, and backward, with scan rates 30, 50, 70 
and 100 mV/s (see Figure 5.3 (A)). For working electrode containing LOx, the potential has 
varied from -100 to 600 mV, and backward, with scan rates 30, 50, 70 and 100 mV/s (see 
Figure 5.3 (B)). 
 
 
Figure 5.3 Cyclic voltammetry curves characterizing the redox activity of vinylferrocene in presence of GOx 
(A) and LOx (B) in the microneedles polymeric matrix at several scan rates; anodic peak current as function of 
square root of scan rate for vinylferrocene with GOx (C) and LOx (D).  
 
As showed in Figure 5.3 (A) and Figure 5.3 (B), the two devices show anodic and cathodic 
peaks at about 300 and 200 mV, respectively, that are very close to typical peaks of free 
vinylferrocene (Ju et al., 1997). This result means that the polymeric matrix, containing GOx 
or LOx, does not interfere with the redox activity of the vinylferrocene. Figure 5.3 (A) and 
Figure 5.3 (B) also highlight that peak positions are unchanged as a function of scan rate and 
that reverse to forward peak current ratio is close to unity for both enzymatic electrodes. 
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Moreover, Figure 5.3 (C) and Figure 5.3 (D) demonstrate that the anodic peaks current 
increases proportionally to the scan rate (R
2
 = 0.95 and R
2
 = 0.91 respectively, R
2
 being the 
coefficient of linear regression) for both enzymatic electrodes. These results suggest that the 
redox activity of the mediator is fast and reversible.  
Chronoamperometry technique quantifies the responses, in terms of current, of the two 
devices at several concentrations of glucose and lactic acid, in concentration ranges of interest 
for the detection in human interstitial fluid (Shim et al., 2009; Shum et al., 2009; Yao et al., 
2011; Thomas et al., 2012). During chronoamperometry measurements, the potential between 
working and reference electrodes is fixed and the current, flowing between working and 
auxiliary electrodes, is measured as function of time. The chronoamperometry characteristics 
are performed at 300 mV, in presence of known analyte concentrations, 5 minutes after 
addition of each aliquot of analyte in order to allow the diffusion inside the electrolytic 
solution. Glucose and lactic acid are detected at the following concentrations: 0, 2, 4, 6, 8, 10, 
12 mM and 0, 0.2, 0.4, 0.6, 0.8, 1, 2, 3, 5, 7, 9, 12 mM, respectively. Figure 5.4 (A) and 
Figure 5.4 (B) report the current-time relationship of the two devices at several concentrations 
of glucose and lactic acid, respectively. 
 
Figure 5.4 Chronoamperometry response of the microneedles based enzymatic electrodes at several 
concentrations of glucose (A) and lactic acid (B); calibrations curves and fits with Michaelis-Menten model of 
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the microneedles based enzymatic electrodes containing GOx (C) and LOx (D). In the inset of (C) and (D), the 
linear region of the response is underlined and the linear fit is showed. 
  
Figure 5.4 (C) and Figure 5.4 (D) illustrate the calibration curves for glucose and lactic acid, 
respectively: for each analyte concentration, the stationary current value is considered. The 
response of the device to glucose is linear (R
2
 value of 0.93) with a sensitivity of 18 ± 3 nA 
mM
-1
 in the range from 0 to 6 mM (see inset Figure 5.4 (C)). The response of the other device 
to lactic acid is linear (R
2
 value of 0.98) with a sensitivity of 3.5 ± 0.2 nA mM
-1
 in the range 
from 0 to 1 mM (see inset Figure 5.4 (D)). Response times are of the order of minutes, and 
they depended on polymer nanostructure: penetration of solution in the microneedle matrix is 
diffusion-driven and faster signal generation can be obtained by tuning its porosity. By using 
a PEGDA with average molecular weight greater than 250, with longer polymeric chains and 
wider mesh, should promote analyte penetration and fasten device response. However, 
PEGDA molecular weight determines microneedles mechanical properties, such as 
indentation hardness; therefore, a tradeoff between analytes diffusion and penetration of the 
microneedles in human skin without breaking could limit the amount of PEGDA in the 
polymeric solution. The experimental data in Figure 5.4 (C) and Figure 5.4 (D) are fitted with 
Michaelis-Menten model for enzymatic kinetic behavior: I=(Imax·c) / (KM + c), where I is the 
current response of the device, c is the analyte concentration and KM is the Michaelis constant. 
The fits yield a KM value of 2.7 ± 0.7 mM (R
2
 = 0.99) in case of glucose, and 0.45 ± 0.03 mM 
(R
2
 = 0.99) in case of lactic acid. The KM represents a measure of how strong is the 
biomolecular interaction between the enzyme and the analyte: the obtained low values are 
related to the high affinity between the enzyme (GOx or LOx) and analyte (glucose or lactic 
acid), confirming that polymeric matrix allow the penetration of the analyte inside it and a 
correct working of the enzyme, even if confined in a nanometric space. The limits of 











6.   Filtration of small molecules by filter based 
microfluidic device 
Since 1990, microfluidics has nowadays developed into a versatile technology with a huge 
plethora of applications. While initially focused on liquid and gases flow through simple 
channel layouts, designs of chips are much more complicated since they could include lot of 
components integrated inside. Large effort has been spent into the integration of unit 
operations on-chip, e.g. sample pre-treatment, mixing of different substances, controlled 
chemical reaction, and separation/purification of products (Sato et al., 2003; Erickson et al., 
2004). Looking at methods used for components integration, many research groups have 
started out with clever designs of silicon chips, using the well-established toolbox of 
semiconductor industry. Lately, a shift toward new approaches increased, aimed to simple 
straightforward integration: mainly application of functionalized coatings, adsorption beads 
and filters. The use of filters in microfluidics is a topic of growing interest. Filter science and 
technology is a broad and highly interdisciplinary field, where process engineering, material 
science and chemistry meet all together. Exploring the boundaries of these fields offers many 
opportunities, and filters have already been used for an impressive range of functions, such as 
separation, purification, dialysis, and so on (Scrimgeour et al., 2011; Che et al., 2013). 
Traditional methods for improving components that can perform separation inside a 
microchannel include fabricating a barrier with reduced channel width (Brody et al., 1996) or 
an array of posts (He et al., 1999). While these approaches are capable of providing a reusable 
filter, the fabrication process can be time consuming and even expensive. Other way to 
fabricate a filter is to create a packed bed column, either by packing beads (Lettieri et al., 
2003) or by in situ photopolymerization (Paustian et al., 2013). The in situ 
photopolymerization allows to control the position and thickness of the filter, simply by 
controlling the position and the parameters of the UV exposure. The pore size of produced 
filters depends of the ratio of the quantities of components contained in the hydrogel and of 
the exposure time to UV light. An additional advantage of this method is its application in 
existing device formats, provided that the used material for make the device is transparent to 
UV light. Disadvantages include the limited range of materials that can be applied. Filters can 
be fabricated using many soft materials such as PDMS, hydrogels and so on. As already 
mentioned, hydrogels based on PEGDA are particularly attractive due to the possibility of 
photo-induced cross-linking by simply adding a photoinitiator in the polymer solution. 




In this chapter results on the microfluidic filter, fabricated as described in the paragraph 2.6, 
made inside the microfluidic device, fabricated as described in the paragraph 2.2, are 
presented. Also the plastic photomask used to make filter, as described in the paragraph 2.6, is 
presented. The operation of the filter is characterized allowing it to filter fluorescent 
molecules of rhodamine.  
6.1.  Plastic photomask 
The fabrication process, described in the paragraph 2.6, allows to fabricate plastic photomasks 
with minimum feature achievable of about 20 μm, therefore it is particularly suitable for the 
fast prototyping of microfluidic devices. A test pattern, containing lines and dots in black and 
white with dimensions from 10 to 100 µm, is designed (see Figure 6.1 (A)) and transferred 
onto photographic film (see Figure 6.1 (B)) using this process. 
 
 
Figure 6.1 (A) Test pattern; (B) plastic photomask. 
 
Figure 6.2 (A) shows in details the plastic photomask, in which the edge are not so straight 
and well defined and there is a transition region of few microns from dark to transparent 
region. Dark regions are due to the presence of small particles of a metallic silver, or dye 
clouds (see Figure 6.2 (B)), developed from silver halide that have received enough white 
light. It is possible to observe the film grain, that has an average thickness of 410 nm and a 
roughness of 120 nm (see Figure 6.2 (C)). However in transparent regions where silver is 
absent, black dots with a diameter from 0.4 to 3.2 μm are found. These defects can be 
neglected for microfluidic applications. 
(A) (B)





Figure 6.2 (A) Optical image of the plastic photomask; zoom (B) and thickness profile (C) of the transition from 
dark to transparent regions.   
 
6.2.  Filter based microfluidic device 
Most of the microfluidic devices are made of PDMS, since it combines numerous excellent 
physical and chemical properties (Bartolo et al., 2008). Nevertheless, some of the properties 
of PDMS strongly limit its range of applications. For example, this silicone elastomer swells 
in most organic solvents that is the major constraint to its use in aqueous solutions. Moreover, 
permanent modification of PDMS surfaces chemical properties is still a challenging task. 
Finally, the low elastic modulus of PDMS does not allow the use of high pressure (> 1 bar) 
operations. In order to overcome these problems, microfluidic devices can be fabricated using 
NOA. Figure 6.3 shows the microfluidic device in NOA fabricated by soft imprint 
lithography, described in the paragraph 2.2. 
 
 
Figure 6.3 (A) Sketch of the microfluidic device; (B) zoom of the circuit. 
 
Nanoports, that are plastic connectors which allow to seal plastic tubes for the injection of the 













The microfluidic device is integrated with a filter, fabricated as described in the paragraph 
2.6. The final microfluidic circuit, showed in Figure 6.4, is thus constituted by two channels 




Figure 6.4 (A) Image of the microfluidic circuit, constituted by the two channels and the filter; (B) zoom of the 
circuit, where the filter separates the top channel from the bottom channel.  
 
6.3.  Optically monitored filtration of rhodamine molecules 
In order to see the operation of the filter, fluorescence molecules of rhodamine 6G (R6G) are 
filtered. The functioning of the filter is characterized in the following (see Figure 6.5). 
 
 
Figure 6.5 Operation of the filter at Q=500 µL/min: fluorescence images (A) and intensities (B) of the two 
channels as function of time. 
 
The two channels are filled with water at flow rate Q of 500 µL/min for some minutes in 
order to clean them. Then, the flow of water in the top channel is stopped (Q ~ 0) and the 
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fluorescent (see Figure 6.5 (A) I). The bottom channel is filled with an aqueous solution of 
R6G at Q=500 µL/min, therefore it becomes completely fluorescent (see Figure 6.5 (A) II). 
The R6G diffuses from the bottom to the top channel through the filter (see Figure 6.5 (A) III, 
IV). After few minutes, the top channel is filled of the R6G (see Figure 6.5 (A) V) therefore it 
becomes completely fluorescent. Figure 6.5 (B) shows the fluorescence intensities as function 
of the time of the bottom and top channels: the intensities tend to become equals after a few 
minutes. 
The reversibility of the device is showed in Figure 6.6. 
 
 
Figure 6.6 Reversibility of the filter at Q=500 µL/min: fluorescence images (A) and intensities (B) of the two 
channels as function of time. 
 
The  two channels, containing an aqueous solution of R6G (Q ~ 0 in the top channel) from the 
previous test, are fluorescent (see Figure 6.6 (A) I). The bottom channel is filled with water at 
Q=500 µL/min, therefore it becomes completely not fluorescent (see Figure 6.6 (A) II). The 
water diffuses from the bottom to the top channel through the filter (see Figure 6.6 (A) III). 
After few minutes, the top channel is filled of water therefore it becomes completely not 
fluorescent. Figure 6.6 (B) shows the fluorescence intensities as function of the time of the 
bottom and top channels: the intensities tend to become equals after a few minutes. 
The same studies were performed by tuning the solution flux at Q=100 µL/min (see Figure 
6.7 and Figure 6.8). 
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Figure 6.7 Operation of the filter at Q=100 µL/min: fluorescence images (A) and intensities (B) of the two 
channels as function of time. 
 
 
Figure 6.8 Reversibility of the filter at Q=100 µL/min: fluorescence images (A) and intensities (B) of the two 
channels as function of time. 
 
The behavior of the system is very similar to the previous one and significant differences 
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7.   Conclusions 
Well established integrated circuits technologies, traditionally used in production of 
microprocessors, are more and more exploited in different fields, very distant from classic 
electronics, such as medicine and biology. However, transferring these technologies from the 
integrated circuit industry to other scientific fields is not trivial, since it requires large efforts 
to adapt traditional materials and processes to these areas or in some cases to develop and use 
alternative materials and processes with respect to traditional ones. Nevertheless, the research 
towards this direction offers amazing potentialities. For example, it gives a unique 
opportunity to fabricate miniaturized devices for a huge variety of applications, like the 
realization of microdevices that have the same functionalities of a conventional laboratory 
equipment, or, in the better cases, the integration of all laboratory functions in a single 
microdevice, the development of tools to make tasks in more efficient and effective way with 
respect to conventional methods, and in some cases in real time and in continuous mode. The 
research activity presented in this PhD thesis is placed in this contest with the aim to define 
new fabrication procedures, combining lithographic processes of both hard and soft materials, 
for the realization of three innovative microdevices for biomedical applications. 
The firsts two microdevices, one for transdermal drug delivery and the other for transdermal 
biosensing, have been fabricated by photolithography. The core of these microdevices is the 
flexible microneedle array. Microneedles have been fabricated with only the 
photolithographic process of a photocurable hydrogel based on PEGDA. No other step, like 
thin layers deposition or etching has been used, thus making the process simple, fast and 
cheap. Microneedles with several heights, bases and curvature radii of the tips have been 
fabricated by changing the UV light intensity or the exposure time to UV light. The height 
varies from about 200 to 2200 µm, the bases are 250 µm and 400 µm, and the curvature 
radius goes from about 2 to 11 µm. Indentation hardness of the microneedles has been 
compared with that of a parafilm M, used as artificial skin very similar to the surface layer of 
the pig skin. Microneedles have an indentation hardness more high than that of the parafilm 
M, thus they are able to penetrate into the skin. A penetration test of microneedles into eight 
parafilm M layers folded on self, that mimics the pig skin, has been performed. Microneedles 
penetrate the first four layers, for a total distance of 640 µm, without breaking. 
The first microdevice, made of a free-standing porous silicon membrane integrated with a 
microneedle array, has been realized and tested for the releasing of fluorescein molecules, 
which can mimic a small drug, into a PBS solution, that mimics the human interstitial fluid. 




The fluorescein molecules have been loaded in the porous silicon membrane, which acts as a 
drug reservoir. At the same time, it allows an optical control of the drug loading since the 
reflectivity spectra of the porous silicon membrane red shifts of about 100 nm. Fluorescein 
molecules diffuse from the porous silicon reservoir to the microneedles: this has been 
confirmed by spectroscopic reflectometry, evidencing a blue shift of about 50 nm of the 
reflectivity spectra of the porous silicon membrane, and by strong fluorescence exhibited by 
microneedle array. The shifts of the reflectivity spectra correspond to changes in color of the 
porous silicon membrane, visible by naked eye, from violet to green and then to blue. The 
diffusion of the fluorescein molecules from the microneedles into the PBS solution has been 
confirmed by the continuous decreasing of the fluorescence intensity of the microneedles 
during the immersion of the device in PBS solution for 2, 4, 8 and 24 hours. Migration of 
fluorescein molecules from porous silicon reservoir to microneedles, and from microneedles 
to PBS solution is only driven by diffusion and conditioned by material properties and 
morphologies: by tuning porosities of silicon and polymer, and changing their surface 
chemistries, every kind of drug (hydrophilic and lipophilic) in any interval of time (very rapid 
or very slow) can be locally administrated without using any external force. 
The second set of microdevices, i.e. microneedles based enzymatic electrodes, made of 
microneedle arrays coated by gold, has been realized and tested for electrochemical detection 
of glucose and lactic acid molecules. The microneedle array of both electrodes contains a 
redox mediator, the vinylferrocene. Moreover, the microneedle array of the electrode for the 
detection of glucose also contains the enzyme GOx, while the other microdevice contains the 
LOx. The redox activity of the vinylferrocene, that carries electrons from the enzyme to the 
surface electrode, has been checked by cyclic voltammetry. These measurements show that 
anodic and cathodic peaks of vinylferrocene, immobilized inside the microneedles, are 300 
mV and 200 mV, for both microdevices. These values are the typical peak values of the free 
vinylferrocene, therefore the polymeric matrix and the other species contained inside the 
microneedles do not affect the redox activity of vinylferrocene. The two microdevices have 
been used to quantify glucose and lactic acid in PBS solutions with concentrations of analytes 
in the mM range, which is the range of interest in the human interstitial fluid in physiologic 
conditions. The calibration curves, i.e. current as function of analyte concentration, show 
good sensitivities, 18 ± 3 nA mM
-1
 and 3.5 ± 0.2 nA mM
-1
 for the detection of glucose and 
lactic acid, respectively. Since the two microdevices have an enzymatic behavior, the 
experimental data of the calibration curves have been fitted by Michaelis-Mentel model: the 
fits yielded a KM value of 2.7 ± 0.7 mM in case of glucose and 0.45 ± 0.03 mM in case of 




lactic acid. The KM estimated are low, which means that there is a high affinity between the 
enzyme (GOx or LOx) immobilized inside the microneedles and the analyte (glucose or lactic 
acid), therefore the activity of the immobilized enzyme is not altered compared to the free 
enzyme. The limit of detection, experimentally measured, is 1 µM for both the two analytes, 
quantified by respective microdevices. 
A homemade fabrication process, based on photographic reduction technique, of photomasks 
on photographic films for fast prototyping of microfluidic devices has been developed. This 
process allows the fabrication of cheap plastic photomasks, with a spatial resolution of about 
20 μm. 
The third microdevice, made of a microfluidic device with a microfluidic filter inside, has 
been realized and tested for the filtration of fluorescent small molecules of R6G. The 
microfluidic device has been realized in NOA by soft imprint lithography, that overcomes the 
PDMS limits and extends the range of its applications, which is the basic material in the 
microfluidic field. The device is constituted by two channels, with height of 25 µm and width 
of 225 µm. The microfluidic filter has been realized inside the microfluidic device by in situ 
photopolymerization of a photocurable hydrogel based on PEGDA using a homemade plastic 
photomask. The advantages of this process are simplicity, speed, and versatility due to the 
possibility of fabricating the filter in any location of any microfluidic circuit. Moreover, it 
allows the use of several standard UV exposure systems, like a microscope coupled with a 
UV lamp, a mask aligner traditionally used for photolithography or a microscope coupled to a 
DMD and a UV lamp. The filter has a height of 25 µm and a width of 50 µm. The operation 
of the filter has been tested: the fluorescent molecules of R6G diffuse from one channel to the 
other channel through the filter, that is constituted of nanopores. Two different flow rates 
have been used, in particular 100 µL/min e 500 µL/min: significant differences between them 
have been not seen. Other characterizations have to be done in order to provide quantitative 
parameters of the filter, like permeability, by measuring the flow rate and the diffusion time, 
in order to allow the use of this microdevice for a specific biomedical application, like 
microdialysis. 
Even if not straightforward nor simple, the shifting of existing and mature technologies from 
the consumer electronics to biomedical world can led to the creation of novel microdevices 
and tools with excellent characteristics and functionalities. However, standard production of 
microdevices and tools that can really replace the existing equipment and methods is still far. 
For evidence of this, it can think to the computer mouse, which took 20 years to appear in the 
Macintosh computer after its first prototype made in the 1960s by Engelbart. Therefore, the 




research, both basic and applied, in this field is active and promising, and others exceptional 
results can be envisaged. 
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